Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
Top Cited Papers
- 1 August 2012
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 82 (4), 454-464
- https://doi.org/10.1038/ki.2012.63
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Complement Factor H Deficiency Accelerates Development of Lupus NephritisJournal of the American Society of Nephrology, 2011
- Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulationJCI Insight, 2010
- Structure of complement fragment C3b–factor H and implications for host protection by complement regulatorsNature Immunology, 2009
- Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathwayKidney International, 2009
- Factor I is required for the development of membranoproliferative glomerulonephritis in factor H–deficient miceJCI Insight, 2008
- Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndromeBlood, 2008
- Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domainsThe Journal of Experimental Medicine, 2007
- Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndromeJournal of Medical Genetics, 2006
- Complement Factor H Gene Abnormalities in Haemolytic Uraemic Syndrome: From Point Mutations to Hybrid GenePLoS Medicine, 2006
- Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomeBlood, 2006